Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

RNTX US Equity

Rein Therapeutics, Inc.Health Care · Pharmaceutical Preparations · CIK 1420565 · FY ends Dec 31
$0.79
+0.02 (+2.84%)
USD · as of 2026-08-19 · marketstack
1 8-K filing · 0 13D · 4 13G
DateEventWhat happened / filerSource
2026-08-1513GSchedule 13G filed — ≥5% beneficial owner (passive) · by ADAR1 Capital Management, LLCsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Lynwood Capital Management Inc.sec.gov ↗
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by LYTTON LAURENCE Wsec.gov ↗
2026-07-218-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-07-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Voss Capital, LPsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-14

Every row is a filed document, checked against its EDGAR index.